For the Inventor, By the Inventor

Enter assignee name

La Jolla, CA, United States of America

The Burnham Institute

USPTO Granted Patents = 94

% Expired Patents = 44.7

EPO Patents = 5

Forward Citations = 1,080

Loading Chart...

Loading Chart...

109 inventors (with patents filed for the assignee):

John C Reed (32 out of 85 patents)

Erkki I Ruoslahti (26 out of 135 patents)

Renata Pasqualini (16 out of 41 patents)

4. Xiao-kun Zhang (8 out of 16 patents)

5. Shi Kun Huang (7 out of 19 patents)

6. Bin Guo (5 out of 7 patents)

7. Siva Kumar Kolluri (5 out of 6 patents)

8. Adam Godzik (5 out of 16 patents)

9. Maurizio Pellecchia (4 out of 24 patents)

10. Bingzhen Lin (4 out of 4 patents)

11. Minoru Fukuda (4 out of 24 patents)

12. Mark Mercola (3 out of 17 patents)

13. Guy S Salvesen (3 out of 5 patents)

14. Ruchika Gupta (3 out of 3 patents)

15. Krzysztof Pawlowski (3 out of 5 patents)

Core Competencies:

Eph Receptor Activity

Cancer Apoptosis

Cell Migration Inhibition

Nuclear Magnetic Resonance

Tumor Homing Molecules

Survivin-Binding Proteins

Angiogenic Homing Molecules

Integrin-Binding Peptides

IAP Protein Regulation

Proapoptotic Compounds

Heart Homing Conjugates

Microsatellite-Instability Tumors

94 patents: Sort by Forward Citations

1. 8461119 - Agents that modulate Eph receptor activity (2013-06-11),

2. 8367644 - Methods and compounds useful to induce apoptosis in cancer cells (2013-02-05),

3. 8273705 - Conversion of apoptotic proteins (2012-09-25),

4. 8188051 - Metadherin polypeptides, encoding nucleic acids and methods of use (2012-05-29),

5. 8105798 - Cytoplasmic activity of retinoid X receptor and its regulation by ligands and dimerization (2012-01-31),

6. 8039255 - Compositions and methods for inhibiting cell migration (2011-10-18),

7. 8037094 - Annotation and publication framework (2011-10-11),

8. 7833980 - Compositions and methods for inhibiting cell migration (2010-11-16),

9. 7812058 - Methods and compounds useful to induce apoptosis in cancer cells (2010-10-12),

10. 7745574 - Compounds that regulate apoptosis (2010-06-29),

11. 7741521 - Inhibition of bid-induced cell-death using small organic molecules (2010-06-22),

12. 7723076 - Use of selective labeling to detect and characterize molecular interactions by nuclear magnetic resonance spectroscopy (2010-05-25),

13. 7674577 - Diagnosis of human glycosylation disorders (2010-03-09),

14. 7655634 - Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis (2010-02-02),

15. 7560242 - Metadherin polypeptides, encoding nucleic acids and methods of use (2009-07-14),

Company Overview

The Burnham Institute, located in La Jolla, California, specializes in the regulation of apoptosis, focusing on critical processes that influence cancer progression and treatment. The institute's research encompasses a range of advanced technologies, including Eph receptor activity, cell migration inhibition, and the development of tumor homing molecules. By exploring survivin-binding proteins and integrin-binding peptides, the Burnham Institute aims to innovate therapeutic strategies that target cancer more effectively, contributing to the broader field of cancer research and treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

94 Patents

#8 in La Jolla, CA

#929 in California

#3,976 in US

#8,194 in the World

La Jolla, CA, United States of America

The Burnham Institute

Forward Citations = 1,080

109 inventors:

John C Reed (32 out of 85 patents)

Erkki I Ruoslahti (26 out of 135 patents)

Renata Pasqualini (16 out of 41 patents)

4. Xiao-kun Zhang (8 out of 16 patents)

5. Shi Kun Huang (7 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The Burnham Institute. Retrieved from https://idiyas.com/company/burnham-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…